ProjectUpdated on 3 September 2025
Estelle Biovita
Business Development Officer at InnoHK Centre for Translational Stem Cell Biology
Hong Kong, China (Hong Kong)
About
Estelle Biovita LTD is a biotechnology company specializing in science-driven skincare and cosmeceutical innovation through its proprietary ingredient, STEM ELIXIR. This breakthrough formulation harnesses the regenerative power of human stem cell secretions to enhance skin repair and renewal. Specially designed for sensitive skin, STEM ELIXIR delivers research-backed benefits including anti-ageing effects, skin barrier restoration, and inflammation relief.
Project Location
- China (Hong Kong)
Project Format
- Public-Private Partnership Project
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Project Planning
Main Project Sector
- Technology
Technology
- Bio-Tech
- Health Technology
Total Project Value
- 500,000 USD or Below
Investment Capital Required
- 1,000,001 to 2,500,000 USD
Interested Format of Cooperation
- Joint Venture
- Open for Negotiation
- R&D Cooperation
Preferred Financing Model
- Open for negotiation
Previous Funding Stage
- None
Main Service(s) Required
- Financial Services
- Professional Services
Organisation
InnoHK Centre for Translational Stem Cell Biology
Hong Kong Science and Technology Park, China (Hong Kong)
Similar opportunities
Project
- No
- Bio-Tech
- Technology
- Joint Venture
- R&D Cooperation
- Project Planning
- Health Technology
- Seed & Pre-Series
- Financial Services
- 500,000 USD or Below
- Open for Negotiation
- Open for negotiation
- Professional Services
- Requisition of Service
- 1,000,001 to 2,500,000 USD
- Public-Private Partnership Project
Daisy Tan
Business Development Officer at InnoHK Centre for Translational Stem Cell Biology
Hong Kong, China (Hong Kong)
Project
- Yes
- None
- Equity
- Technology
- Manufacturing
- Private Project
- 500,000 USD or Below
- Open for Negotiation
- Open for negotiation
- Minority Shareholdings
- 1,000,001 to 2,500,000 USD
- Feasibility Study Completed
- Information Technology Services
XIANGQIAN SHI
CEO at Hopebotics
HONG KONG, China (Hong Kong)
Project
- No
- None
- Bio-Tech
- Operations
- Technology
- E-commerce
- Private Project
- Open for negotiation
- Minority Shareholdings
- Transportation Services
- 500,001 to 1,000,000 USD
- 500,001 to 1,000,000 USD
- Import & Export Solutions
- Information Technology Services
LU XU
Founder at Westelite Capital
Hangzhou, China